Therapeutic Action
First line antituberculosis antibacterial (bacteriostatic activity)
Source page 135
Loading InternPractice…
Individual generic drug information
Extracted information for ETHAMBUTOL only.
First line antituberculosis antibacterial (bacteriostatic activity)
Source page 135
Tuberculosis, in combination with other antituberculosis antibacterials
Source page 135
Extracted information for ETHAMBUTOL only.
Do not administer to patients with severe renal impairment or pre-existing optic neuritis (e.g. diabetic retinopathy). May cause: dose-related retrobulbar optic neuritis, exacerbated in renal impairment. Patients should be warned that they must immediately stop treatment and seek medical attention in the event of visual disturbances such as blurred vision, reduced visual acuity, green-red colour blindness. Visual alterations are usually reversible a few weeks after stopping ethambutol. The dosage must be carefully adjusted to the body weight, especially for children under 5 years, as it is more difficult to detect visual alterations at this age. Pregnancy: no contra-indication Breast-feeding: no contra-indication
Source page 135
Extracted information for ETHAMBUTOL only.
100 mg and 400 mg tablets 50 mg and 100 mg dispersible tablets
Source page 135
Child and adult: 15 to 25 mg/kg once daily Do not exceed 1200 mg daily. Patient with renal impairment: 15 to 25 mg/kg 3 times weekly
Source page 135
According to protocol
Source page 135
Extracted information for ETHAMBUTOL only.
For patients sensitive to first-line antituberculosis treatment, ethambutol is given as part of a fixed dose combination.
Source page 136
– – Below 25 °C
Source page 136
Filter the extracted dose blocks for this individual drug.
15 to 25 mg/kg once daily
Candidate age grouping · source page 135